China Universal Asset Management Company’s Kyverna Therapeutics KYTX Stock Holding History

China Universal Asset Management Company’s Portfolio KYTX Stock Details KYTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.2K	Sell	9,676 -462	-5%	-$4.1K	0.01%	425
2026 Q1	$87.5K	Buy	10,138 +3,001	+42%	+$25K	0.01%	417
2025 Q4	$67.1K	Sell	7,137 -443	-6%	-$3.29K	0.01%	436
2025 Q3	$45.5K	Sell	7,580 -1,100	-13%	-$4.4K	﹤0.01%	439
2025 Q2	$26.6K	Buy	8,680 +21	+0.2%	+$52	﹤0.01%	443
2025 Q1	$16.7K	Sell	8,659 -495	-5%	-$1.46K	﹤0.01%	460
2024 Q4	$34.2K	Buy	+9,154	New	+$43.9K	﹤0.01%	469

Other funds holding KYTX

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

China Universal Asset Management Company's KYTX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Kyverna Therapeutics (KYTX) stake by 4.6% in Q2 2026, selling an estimated $4.1K and leaving 9,676 shares worth $86.2K. The position accounts for 0.01% of the portfolio, ranked #425.

China Universal Asset Management Company first reported a position in KYTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $87.5K in Q1 2026. 59 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

China Universal Asset Management Company held 9,676 shares of Kyverna Therapeutics worth $86.2K as of Q2 2026.
China Universal Asset Management Company sold 462 Kyverna Therapeutics shares in Q2 2026, an estimated $4.1K.
Kyverna Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #425 holding.
China Universal Asset Management Company first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 7 quarters since.
China Universal Asset Management Company's Kyverna Therapeutics position peaked at $87.5K in Q1 2026.
59 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.